Anika to Issue Third Quarter 2020 Financial Results and Business Highlights on Wednesday, November 4, 2020
October 22 2020 - 4:05PM
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint
preservation company that creates and delivers meaningful
advancements in early intervention orthopedic care, today announced
that the Company plans to issue its third quarter 2020 financial
results after the close of the market on Wednesday,
November 4, 2020 and hold its investor conference call on the
same day, at 5:00 p.m. ET to discuss its financial results and
business highlights.
The conference call can be accessed by dialing 1-855-327-6837
(toll-free domestic) or 1-631-891-4304 (international) and
providing the conference ID number 10011177. A live audio webcast
will be available in the "Investor Relations" section of Anika's
website, www.anika.com. An accompanying slide presentation also can
be accessed via the Anika website. The call will be archived and
accessible on the same website shortly after its conclusion.
About Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint
preservation company that creates and delivers meaningful
advancements in early intervention orthopedic care. We partner with
physicians to understand what they need most to treat their
patients and we develop minimally invasive products that restore
active living for people around the world. We are committed to
leading in high opportunity spaces within orthopedics, including
osteoarthritis pain management, regenerative solutions, soft tissue
repair and bone preserving joint technologies. For more
information, please visit www.anika.com.
For Investor Inquiries:Anika Therapeutics, Inc.Kristen Galfetti,
781-457-9000Executive Director, Investor
Relationsinvestorrelations@anika.com |
For Media Inquiries:W2O GroupRachel Girard, 617-379-6760
rgirard@w2ogroup.com |
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Apr 2023 to Apr 2024